http://www.pharmaceutical-technology.com/comment/new-rsv-therapies/
0
0
2/1/23 at 12:34pm
Organization
Pharmaceutical Technology
Author
GlobalData Healthcare
29 words
0
Comments
Regularly monitoring RSV sequences will be critical to ensure that approved mAbs remain effective against circulating strains.
You are the first to view
Create an account
or login to join the discussion